Abstract
Inflammatory Bowel Diseases (IBD) are idiopathic chronic inflammation of the gastrointestinal tract. In recent decades, they have gained relevance due to a significant increase in their incidence and prevalence. Currently, the IBD treatment is based on drugs that act on anti-inflammatory pathways, with several cases with non-responsive patients or with significant side effects. Given this…